Perfusion Market Report

Global Perfusion Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 02, 2022
  • PAGES：191
  • REPORT CODE：GMM792468
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Perfusion market report explains the definition, types, applications, major countries, and major players of the Perfusion market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Merck

    • Spectrum Laboratories

    • Ala Science

    • Repligen Corporation

    • Lifeline Scientific

    • Getinge

    • Harvard Bioscience

    • XVIVO Perfusion

    • Medtronic

    • Xenios

    • Terumo Medical

    • LivaNova

    By Type:

    • Cardiopulmonary Bypass

    • Extracorporeal Membrane Oxygenation

    • Isolated Limb Perfusion

    By End-User:

    • Lungs

    • Heart

    • Liver

    • Kidney

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Perfusion Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Perfusion Outlook to 2028- Original Forecasts

    • 2.2 Perfusion Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Perfusion Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Perfusion Market- Recent Developments

    • 6.1 Perfusion Market News and Developments

    • 6.2 Perfusion Market Deals Landscape

    7 Perfusion Raw Materials and Cost Structure Analysis

    • 7.1 Perfusion Key Raw Materials

    • 7.2 Perfusion Price Trend of Key Raw Materials

    • 7.3 Perfusion Key Suppliers of Raw Materials

    • 7.4 Perfusion Market Concentration Rate of Raw Materials

    • 7.5 Perfusion Cost Structure Analysis

      • 7.5.1 Perfusion Raw Materials Analysis

      • 7.5.2 Perfusion Labor Cost Analysis

      • 7.5.3 Perfusion Manufacturing Expenses Analysis

    8 Global Perfusion Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Perfusion Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Perfusion Export by Region (Top 10 Countries) (2017-2028)

    9 Global Perfusion Market Outlook by Types and Applications to 2022

    • 9.1 Global Perfusion Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Cardiopulmonary Bypass Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Extracorporeal Membrane Oxygenation Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Isolated Limb Perfusion Consumption and Growth Rate (2017-2022)

    • 9.2 Global Perfusion Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Lungs Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Heart Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Liver Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Kidney Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Perfusion Market Analysis and Outlook till 2022

    • 10.1 Global Perfusion Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Perfusion Consumption (2017-2022)

      • 10.2.2 Canada Perfusion Consumption (2017-2022)

      • 10.2.3 Mexico Perfusion Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Perfusion Consumption (2017-2022)

      • 10.3.2 UK Perfusion Consumption (2017-2022)

      • 10.3.3 Spain Perfusion Consumption (2017-2022)

      • 10.3.4 Belgium Perfusion Consumption (2017-2022)

      • 10.3.5 France Perfusion Consumption (2017-2022)

      • 10.3.6 Italy Perfusion Consumption (2017-2022)

      • 10.3.7 Denmark Perfusion Consumption (2017-2022)

      • 10.3.8 Finland Perfusion Consumption (2017-2022)

      • 10.3.9 Norway Perfusion Consumption (2017-2022)

      • 10.3.10 Sweden Perfusion Consumption (2017-2022)

      • 10.3.11 Poland Perfusion Consumption (2017-2022)

      • 10.3.12 Russia Perfusion Consumption (2017-2022)

      • 10.3.13 Turkey Perfusion Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Perfusion Consumption (2017-2022)

      • 10.4.2 Japan Perfusion Consumption (2017-2022)

      • 10.4.3 India Perfusion Consumption (2017-2022)

      • 10.4.4 South Korea Perfusion Consumption (2017-2022)

      • 10.4.5 Pakistan Perfusion Consumption (2017-2022)

      • 10.4.6 Bangladesh Perfusion Consumption (2017-2022)

      • 10.4.7 Indonesia Perfusion Consumption (2017-2022)

      • 10.4.8 Thailand Perfusion Consumption (2017-2022)

      • 10.4.9 Singapore Perfusion Consumption (2017-2022)

      • 10.4.10 Malaysia Perfusion Consumption (2017-2022)

      • 10.4.11 Philippines Perfusion Consumption (2017-2022)

      • 10.4.12 Vietnam Perfusion Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Perfusion Consumption (2017-2022)

      • 10.5.2 Colombia Perfusion Consumption (2017-2022)

      • 10.5.3 Chile Perfusion Consumption (2017-2022)

      • 10.5.4 Argentina Perfusion Consumption (2017-2022)

      • 10.5.5 Venezuela Perfusion Consumption (2017-2022)

      • 10.5.6 Peru Perfusion Consumption (2017-2022)

      • 10.5.7 Puerto Rico Perfusion Consumption (2017-2022)

      • 10.5.8 Ecuador Perfusion Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Perfusion Consumption (2017-2022)

      • 10.6.2 Kuwait Perfusion Consumption (2017-2022)

      • 10.6.3 Oman Perfusion Consumption (2017-2022)

      • 10.6.4 Qatar Perfusion Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Perfusion Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Perfusion Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Perfusion Consumption (2017-2022)

      • 10.7.2 South Africa Perfusion Consumption (2017-2022)

      • 10.7.3 Egypt Perfusion Consumption (2017-2022)

      • 10.7.4 Algeria Perfusion Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Perfusion Consumption (2017-2022)

      • 10.8.2 New Zealand Perfusion Consumption (2017-2022)

    11 Global Perfusion Competitive Analysis

    • 11.1 Merck

      • 11.1.1 Merck Company Details

      • 11.1.2 Merck Perfusion Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Merck Perfusion Main Business and Markets Served

      • 11.1.4 Merck Perfusion Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Spectrum Laboratories

      • 11.2.1 Spectrum Laboratories Company Details

      • 11.2.2 Spectrum Laboratories Perfusion Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Spectrum Laboratories Perfusion Main Business and Markets Served

      • 11.2.4 Spectrum Laboratories Perfusion Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Ala Science

      • 11.3.1 Ala Science Company Details

      • 11.3.2 Ala Science Perfusion Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Ala Science Perfusion Main Business and Markets Served

      • 11.3.4 Ala Science Perfusion Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Repligen Corporation

      • 11.4.1 Repligen Corporation Company Details

      • 11.4.2 Repligen Corporation Perfusion Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Repligen Corporation Perfusion Main Business and Markets Served

      • 11.4.4 Repligen Corporation Perfusion Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Lifeline Scientific

      • 11.5.1 Lifeline Scientific Company Details

      • 11.5.2 Lifeline Scientific Perfusion Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Lifeline Scientific Perfusion Main Business and Markets Served

      • 11.5.4 Lifeline Scientific Perfusion Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Getinge

      • 11.6.1 Getinge Company Details

      • 11.6.2 Getinge Perfusion Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Getinge Perfusion Main Business and Markets Served

      • 11.6.4 Getinge Perfusion Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Harvard Bioscience

      • 11.7.1 Harvard Bioscience Company Details

      • 11.7.2 Harvard Bioscience Perfusion Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Harvard Bioscience Perfusion Main Business and Markets Served

      • 11.7.4 Harvard Bioscience Perfusion Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 XVIVO Perfusion

      • 11.8.1 XVIVO Perfusion Company Details

      • 11.8.2 XVIVO Perfusion Perfusion Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 XVIVO Perfusion Perfusion Main Business and Markets Served

      • 11.8.4 XVIVO Perfusion Perfusion Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Medtronic

      • 11.9.1 Medtronic Company Details

      • 11.9.2 Medtronic Perfusion Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Medtronic Perfusion Main Business and Markets Served

      • 11.9.4 Medtronic Perfusion Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Xenios

      • 11.10.1 Xenios Company Details

      • 11.10.2 Xenios Perfusion Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Xenios Perfusion Main Business and Markets Served

      • 11.10.4 Xenios Perfusion Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Terumo Medical

      • 11.11.1 Terumo Medical Company Details

      • 11.11.2 Terumo Medical Perfusion Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Terumo Medical Perfusion Main Business and Markets Served

      • 11.11.4 Terumo Medical Perfusion Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 LivaNova

      • 11.12.1 LivaNova Company Details

      • 11.12.2 LivaNova Perfusion Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 LivaNova Perfusion Main Business and Markets Served

      • 11.12.4 LivaNova Perfusion Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    12 Global Perfusion Market Outlook by Types and Applications to 2028

    • 12.1 Global Perfusion Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Cardiopulmonary Bypass Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Extracorporeal Membrane Oxygenation Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Isolated Limb Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Perfusion Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Lungs Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Heart Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Liver Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Kidney Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Perfusion Market Analysis and Outlook to 2028

    • 13.1 Global Perfusion Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Perfusion Consumption Forecast (2022-2028)

      • 13.2.2 Canada Perfusion Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Perfusion Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Perfusion Consumption Forecast (2022-2028)

      • 13.3.2 UK Perfusion Consumption Forecast (2022-2028)

      • 13.3.3 Spain Perfusion Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Perfusion Consumption Forecast (2022-2028)

      • 13.3.5 France Perfusion Consumption Forecast (2022-2028)

      • 13.3.6 Italy Perfusion Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Perfusion Consumption Forecast (2022-2028)

      • 13.3.8 Finland Perfusion Consumption Forecast (2022-2028)

      • 13.3.9 Norway Perfusion Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Perfusion Consumption Forecast (2022-2028)

      • 13.3.11 Poland Perfusion Consumption Forecast (2022-2028)

      • 13.3.12 Russia Perfusion Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Perfusion Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Perfusion Consumption Forecast (2022-2028)

      • 13.4.2 Japan Perfusion Consumption Forecast (2022-2028)

      • 13.4.3 India Perfusion Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Perfusion Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Perfusion Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Perfusion Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Perfusion Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Perfusion Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Perfusion Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Perfusion Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Perfusion Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Perfusion Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Perfusion Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Perfusion Consumption Forecast (2022-2028)

      • 13.5.3 Chile Perfusion Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Perfusion Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Perfusion Consumption Forecast (2022-2028)

      • 13.5.6 Peru Perfusion Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Perfusion Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Perfusion Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Perfusion Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Perfusion Consumption Forecast (2022-2028)

      • 13.6.3 Oman Perfusion Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Perfusion Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Perfusion Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Perfusion Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Perfusion Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Perfusion Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Perfusion Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Perfusion Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Perfusion Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Perfusion Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Perfusion

    • Figure of Perfusion Picture

    • Table Global Perfusion Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Perfusion Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Cardiopulmonary Bypass Consumption and Growth Rate (2017-2022)

    • Figure Global Extracorporeal Membrane Oxygenation Consumption and Growth Rate (2017-2022)

    • Figure Global Isolated Limb Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Global Lungs Consumption and Growth Rate (2017-2022)

    • Figure Global Heart Consumption and Growth Rate (2017-2022)

    • Figure Global Liver Consumption and Growth Rate (2017-2022)

    • Figure Global Kidney Consumption and Growth Rate (2017-2022)

    • Figure Global Perfusion Consumption by Country (2017-2022)

    • Table North America Perfusion Consumption by Country (2017-2022)

    • Figure United States Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Canada Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Mexico Perfusion Consumption and Growth Rate (2017-2022)

    • Table Europe Perfusion Consumption by Country (2017-2022)

    • Figure Germany Perfusion Consumption and Growth Rate (2017-2022)

    • Figure UK Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Spain Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Belgium Perfusion Consumption and Growth Rate (2017-2022)

    • Figure France Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Italy Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Denmark Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Finland Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Norway Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Sweden Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Poland Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Russia Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Turkey Perfusion Consumption and Growth Rate (2017-2022)

    • Table APAC Perfusion Consumption by Country (2017-2022)

    • Figure China Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Japan Perfusion Consumption and Growth Rate (2017-2022)

    • Figure India Perfusion Consumption and Growth Rate (2017-2022)

    • Figure South Korea Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Thailand Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Singapore Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Philippines Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Perfusion Consumption and Growth Rate (2017-2022)

    • Table South America Perfusion Consumption by Country (2017-2022)

    • Figure Brazil Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Colombia Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Chile Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Argentina Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Peru Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Perfusion Consumption and Growth Rate (2017-2022)

    • Table GCC Perfusion Consumption by Country (2017-2022)

    • Figure Bahrain Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Oman Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Qatar Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Perfusion Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Perfusion Consumption and Growth Rate (2017-2022)

    • Table Africa Perfusion Consumption by Country (2017-2022)

    • Figure Nigeria Perfusion Consumption and Growth Rate (2017-2022)

    • Figure South Africa Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Egypt Perfusion Consumption and Growth Rate (2017-2022)

    • Figure Algeria Perfusion Consumption and Growth Rate (2017-2022)

    • Table Oceania Perfusion Consumption by Country (2017-2022)

    • Figure Australia Perfusion Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Perfusion Consumption and Growth Rate (2017-2022)

    • Table Merck Company Details

    • Table Merck Perfusion Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Perfusion Main Business and Markets Served

    • Table Merck Perfusion Product Portfolio

    • Table Spectrum Laboratories Company Details

    • Table Spectrum Laboratories Perfusion Sales, Price, Value and Gross Profit (2017-2022)

    • Table Spectrum Laboratories Perfusion Main Business and Markets Served

    • Table Spectrum Laboratories Perfusion Product Portfolio

    • Table Ala Science Company Details

    • Table Ala Science Perfusion Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ala Science Perfusion Main Business and Markets Served

    • Table Ala Science Perfusion Product Portfolio

    • Table Repligen Corporation Company Details

    • Table Repligen Corporation Perfusion Sales, Price, Value and Gross Profit (2017-2022)

    • Table Repligen Corporation Perfusion Main Business and Markets Served

    • Table Repligen Corporation Perfusion Product Portfolio

    • Table Lifeline Scientific Company Details

    • Table Lifeline Scientific Perfusion Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lifeline Scientific Perfusion Main Business and Markets Served

    • Table Lifeline Scientific Perfusion Product Portfolio

    • Table Getinge Company Details

    • Table Getinge Perfusion Sales, Price, Value and Gross Profit (2017-2022)

    • Table Getinge Perfusion Main Business and Markets Served

    • Table Getinge Perfusion Product Portfolio

    • Table Harvard Bioscience Company Details

    • Table Harvard Bioscience Perfusion Sales, Price, Value and Gross Profit (2017-2022)

    • Table Harvard Bioscience Perfusion Main Business and Markets Served

    • Table Harvard Bioscience Perfusion Product Portfolio

    • Table XVIVO Perfusion Company Details

    • Table XVIVO Perfusion Perfusion Sales, Price, Value and Gross Profit (2017-2022)

    • Table XVIVO Perfusion Perfusion Main Business and Markets Served

    • Table XVIVO Perfusion Perfusion Product Portfolio

    • Table Medtronic Company Details

    • Table Medtronic Perfusion Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Perfusion Main Business and Markets Served

    • Table Medtronic Perfusion Product Portfolio

    • Table Xenios Company Details

    • Table Xenios Perfusion Sales, Price, Value and Gross Profit (2017-2022)

    • Table Xenios Perfusion Main Business and Markets Served

    • Table Xenios Perfusion Product Portfolio

    • Table Terumo Medical Company Details

    • Table Terumo Medical Perfusion Sales, Price, Value and Gross Profit (2017-2022)

    • Table Terumo Medical Perfusion Main Business and Markets Served

    • Table Terumo Medical Perfusion Product Portfolio

    • Table LivaNova Company Details

    • Table LivaNova Perfusion Sales, Price, Value and Gross Profit (2017-2022)

    • Table LivaNova Perfusion Main Business and Markets Served

    • Table LivaNova Perfusion Product Portfolio

    • Figure Global Cardiopulmonary Bypass Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Extracorporeal Membrane Oxygenation Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Isolated Limb Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lungs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Heart Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Liver Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kidney Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Perfusion Consumption Forecast by Country (2022-2028)

    • Table North America Perfusion Consumption Forecast by Country (2022-2028)

    • Figure United States Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Perfusion Consumption Forecast by Country (2022-2028)

    • Figure Germany Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Perfusion Consumption Forecast by Country (2022-2028)

    • Figure China Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Perfusion Consumption Forecast by Country (2022-2028)

    • Figure Brazil Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Perfusion Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Perfusion Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Perfusion Consumption Forecast by Country (2022-2028)

    • Figure Australia Perfusion Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Perfusion Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US